1
408
M. Zhang, F.-Z. Hu, T. Zhao, L.-Q. Yang, and H.-Z. Yang
Vol 51
À1
n: 3140, 3031, 2923, 2858, 1607, 1441, 1398, 1289, 1253, 1217,
747 cm . Anal. Calcd for C H N O : C, 63.77; H, 6.36; N,
1
6 19 3 3
À1
1
123, 1022, 978, 906, 834, 696 cm . Anal. Calcd for
13.94. Found: C, 63.74; H, 6.41; N, 13.75.
C
7
18
H
23
N
3
O: C, 72.70; H, 7.80; N, 14.13. Found: C, 72.64; H,
.64; N, 14.31.
-(1-Piperidinyl)-6-(4-bromobenzyloxy)pyridazine (5i). White
3-(4-Morpholinyl)-6-(4-bromobenzyloxy)pyridazine (5p). White
ꢀ
1
solid, mp 165–166 C, yield 89.7%;
3
H-NMR(CDCl ,
3
300 MHz) d: 3.49 (t, J= 4.8 Hz, 4H, CH NCH ), 3.84 (t, J=4.8Hz,
2
2
ꢀ
1
solid, mp 132–133 C, yield 72.4%; H-NMR(CDCl
.63–1.74 (m, 6H, (CH ), 3.48–3.58 (m, 4H, CH
s, 2H, CH O), 6.87 (d, J= 9.6 Hz, 1H, pyridazine-H), 7.05
3
, 300 MHz) d:
4H, CH OCH ), 5.42 (s, 2H, CH O), 6.91 (d, J= 9.6 Hz, 1H,
2 2 2
1
(
2
)
3
2
NCH ), 5.43
2
pyridazine-H), 7.02 (d, J= 9.6 Hz, 1H, pyridazine-H), 7.35
(d, J= 8.4 Hz, 2H, ArH), 7.50 (d, J= 8.4 Hz, 2H, ArH); IR (KBr) n:
3140, 3017, 1629, 1542, 1398, 1289, 1239, 1108, 920, 870,
2
(d, J= 9.6 Hz, 1H, pyridazine-H), 7.36 (d, J= 8.4 Hz, 2H, ArH),
À1
7.51 (d, J= 8.4 Hz, 2H, ArH); IR (KBr) n: 3118, 1614, 1398, 1239,
834 cm . Anal. Calcd for C H BrN O : C, 51.44; H, 4.60; N,
15
16
3 2
À1
1101, 1007, 790 cm . Anal. Calcd for C16
3
H18BrN O: C, 55.18; H,
12.00. Found: C, 51.58; H, 4.51; N, 12.01.
5
.21; N, 12.07. Found: C, 54.95; H, 5.24; N, 11.97.
-(1-Piperidinyl)-6-(4-nitrobenzyloxy)pyridazine (5j). Yellow
3-(4-Morpholinyl)-6-(4-nitrobenzyloxy)pyridazine (5q). Yellow
ꢀ
1
3
solid, mp 197–199 C, yield 73.0%; H-NMR(CDCl , 300 MHz)
3
ꢀ
1
solid, mp 148–149 C, yield 80.0%; H-NMR(CDCl , 300 MHz) d:
d: 3.50 (t, J=4.8Hz, 4H, CH NCH ), 3.85 (t, J=4.8Hz, 4H,
3
2
2
1
(
(
.63–1.71 (m, 6H, (CH
s, 2H, CH O), 6.91 (d, J= 9.6 Hz, 1H, pyridazine-H), 7.06
d, J= 9.6 Hz, 1H, pyridazine-H), 7.62 (d, J= 8.7 Hz, 2H, ArH),
2
)
3
), 3.47–3.56 (m, 4H, CH
2
NCH
2
), 5.57
CH OCH ), 5.58 (s, 2H, CH O), 6.98 (d, J= 9.6 Hz, 1H, pyridazine-H),
2 2 2
2
7.06 (d, J= 9.6 Hz, 1H, pyridazine-H), 7.63 (d, J= 8.7 Hz, 2H, ArH),
8.23 (d, J= 8.7 Hz, 2H, ArH); IR (KBr) n: 3140, 3010, 2858, 1600,
À1
8.23 (d, J= 8.7 Hz, 2H, ArH); IR (KBr) n: 3125, 3017, 2937, 2858,
1506, 1398, 1340, 1296, 1246, 1108, 1029, 920, 834 cm . Anal. Calcd
À1
1600, 1520, 1405, 1347, 1296, 1239, 1108, 1043, 906, 827 cm
.
for C H N O : C, 56.96; H, 5.10; N, 17.71. Found: C, 56.75; H, 5.39;
15 16 4 4
Anal. Calcd for C16
C, 60.95; H, 5.60; N, 18.01.
-(1-Piperidinyl)-6-(2-fluorobenzyloxy)pyridazine (5k). White
H
18
N
4
O
3
: C, 61.13; H, 5.77; N, 17.82. Found:
N, 17.69.
3-(4-Morpholinyl)-6-(2-fluorobenzyloxy)pyridazine (5r). White
ꢀ
1
3
solid, mp 115–116 C, yield 82.6%; H-NMR(CDCl , 300 MHz) d:
3
ꢀ
1
solid, mp 64–65 C, yield 88.9%; H-NMR(CDCl , 300 MHz) d:
3.52 (t, J= 4.8 Hz, 4H, CH NCH ), 3.87 (t, J=4.8Hz, 4H,
3
2
2
1
.60–1.74 (m, 6H, (CH
2
)
3
), 3.45–3.58 (m, 4H, CH
2
NCH
2
), 5.53
2 2 2
CH OCH ), 5.56 (s, 2H, CH O), 6.94 (d, J= 9.6 Hz, 1H, pyridazine-
(
s, 2H, CH
2
O), 6.86 (d, J= 9.6 Hz, 1H, pyridazine-H),
H), 7.04 (d, J= 9.6 Hz, 1H, pyridazine-H), 7.07–7.21 (m, 2H, ArH),
7.30–7.39 (m, 1H, ArH), 7.50–7.58 (m, 1H, ArH); IR (KBr) n:
3133, 2981, 2858, 1614, 1448, 1398, 1296, 1246, 1217, 1108, 1029,
7
7
3
1
.04 (d, J= 9.9 Hz, 1H, pyridazine-H), 7.07–7.19 (m, 2H, ArH),
.27–7.37 (m, 1H, ArH), 7.48–7.56 (m, 1H, ArH); IR (KBr) n:
125, 2937, 2865, 2814, 1484, 1441, 1398, 1296, 1246, 1116,
007, 906, 834, 747 cm . Anal. Calcd for C16
À1
928, 834, 740 cm . Anal. Calcd for C H FN O : C, 62.27; H,
15
16
3 2
À1
3
H18FN O: C, 66.88;
5.57; N, 14.52. Found: C, 62.15; H, 5.62: N, 14.58.
3-(4-Morpholinyl)-6-(3-fluorobenzyloxy)pyridazine (5s). White
H, 6.31; N, 14.62. Found: C, 66.87; H, 6.31; N, 14.55.
-(1-Piperidinyl)-6-(3-fluorobenzyloxy)pyridazine (5l). White
solid, mp 80 C, yield 90.5%; H-NMR(CDCl
ꢀ
1
3
solid, mp 122–123 C, yield 84.8%; H-NMR(CDCl , 300 MHz)
3
ꢀ
1
3
, 300 MHz) d:
NCH ), 5.45
d: 3.50 (t, J=4.8Hz, 4H, CH NCH ), 3.85 (t, J=4.8Hz, 4H,
2
2
1
.58–1.72 (m, 6H, (CH ), 3.37–3.57 (m, 4H, CH
)
2 3
2
2
2 2 2
CH OCH ), 5.47 (s, 2H, CH O), 6.89–7.08 (m, 3H, pyridazine-
(
(
(
s, 2H, CH O), 6.88 (d, J = 9.6Hz, 1H, pyridazine-H), 6.95–7.09
m, 2H, pyridazine-H+ ArH), 7.14–7.25 (m, 2H, ArH), 7.28–7.38
H+ArH), 7.12–7.40 (m, 3H, ArH); IR (KBr) n: 3125, 2973, 2865,
2
1622, 1586, 1455, 1398, 1289, 1246, 1094, 1014, 928, 827, 776,
À1
m, 1H, ArH); IR (KBr) n: 3125, 2937, 2822, 1614, 1586, 1441,
675 cm . Anal. Calcd for C H FN O : C, 62.27; H, 5.57; N,
1
5
16
3 2
À1
1
398, 1296, 1246, 1130, 1014, 913, 834, 776, 747cm . Anal.
14.52. Found: C, 62.25; H, 5.41; N, 14.55.
Calcd for C16
6.85; H, 6.24; N, 14.72.
-(1-Piperidinyl)-6-(4-fluorobenzyloxy)pyridazine (5m). White
H
18FN
3
O: C, 66.88; H, 6.31; N, 14.62. Found: C,
3-(4-Morpholinyl)-6-(4-fluorobenzyloxy)pyridazine (5t). White
ꢀ
1
6
solid, mp 138–139 C, yield 76.7%; H-NMR(CDCl
d: 3.49 (t, J= 4.8 Hz, 4H, CH NCH ), 3.84 (t, J= 4.8 Hz, 4H,
CH OCH ), 5.42 (s, 2H, CH O), 6.91 (d, J= 9.6 Hz, 1H,
3
, 400 MHz)
3
2
2
ꢀ
1
solid, mp 111–112 C, yield 91.8%; H-NMR(CDCl
3
, 300MHz) d:
2
2
2
1
2
3
3
.60–1.74 (m, 6H, (CH ) ), 3.38–3.57 (m, 4H, CH NCH ), 5.42 (s,
pyridazine-H), 7.02 (d, J= 9.6 Hz, 1H, pyridazine-H), 7.03–7.09
(m, 2H, ArH), 7.41–7.47 (m, 2H, ArH); IR (KBr) n: 3140, 2973,
2
3
2
2
H, CH O), 6.85 (d, J= 9.9 Hz, 1H, pyridazine-H), 7.01–7.10 (m,
2
H, pyridazine-H + ArH), 7.40–7.49 (m, 2H, ArH); IR (KBr) n:
2872, 1614, 1520, 1448, 1398, 1296, 1239, 1108, 1022, 920,
À1
À1
140, 2930, 1607, 1434, 1390, 1210, 1108, 1007, 812 cm . Anal.
819 cm . Anal. Calcd for C15
H
16FN
3
O
2
: C, 62.27; H, 5.57; N,
Calcd for C H FN O: C, 66.88; H, 6.31; N, 14.62. Found: C,
14.52. Found: C, 62.29; H, 5.40; N, 14.58.
16
18
3
6
6.95; H, 6.21; N, 14.72.
Bioassays. The herbicidal activities of the title compounds
3
-(4-Morpholinyl)-6-benzyloxypyridazine (5n). White solid,
were evaluated using a previously reported procedure [16,17]. For
glasshouse tests, all the experiments were performed under natural
ꢀ
1
mp 135–136 C, yield 80.5%; H-NMR(CDCl , 300 MHz) d: 3.50
3
ꢀ
(t, J=4.80Hz, 4H, CH NCH ), 3.85 (t, J= 4.80 Hz, 4H, CH OCH ),
light conditions at 18–28 C. Additionally, adverse weather
2
2
2
2
5
.47 (s, 2H, CH
2
O), 6.92 (d, J= 9.6 Hz, 1H, pyridazine-H), 7.02
lighting was provided using sodium vapor lamps with a 12:12h
light: dark photoperiod. For all of the bioassay tests, each
treatment was repeated two times.
(d, J= 9.6 Hz, 1H, pyridazine-H), 7.30–7.49 (m, 5H, PhH); IR (KBr)
n: 3003, 2867, 1607, 1455, 1297, 1255, 1112, 1026, 930, 829, 730,
À1
690 cm . Anal. Calcd for C H N O : C, 66.40; H, 6.32; N, 15.49.
Treatment.
The emulsions of purified compounds were
15 17 3 2
Found: C, 66.23; H, 6.25; N, 15.55.
-(4-Morpholinyl)-6-(2-methoxybenzyloxy)pyridazine
prepared by dissolving them in 100mL of N,N-dimethylformamide
with the addition of a little Tween 20 and proper water. For
glasshouse tests, the emulsions were sprayed using a laboratory
belt sprayer at 750L/ha. The mixture of the same amount of
water, N,N-dimethylformamide, and Tween 20 was used as control.
Inhibition of the root growth of rape (B. campestris). Rape
seeds were soaked in distilled water for 4 h before being placed on a
filter paper in a 6-cm Petri plate, to which 2 mL of inhibitor solution
3
ꢀ
1
(
5o). White solid, mp 86–87 C, yield 69.8%; H-NMR(CDCl
3
,
3
00 MHz) d: 3.50 (t, J = 4.8 Hz, 4H, CH NCH ), 3.80–3.89
2
2
(
(
(
m, 7H, CH OCH +OCH ), 5.52 (s, 2H, CH O), 6.88–7.04
m, 4H, pyridazine-H+ ArH), 7.27–7.35 (m, 1H, ArH), 7.43–7.50
m, 1H, ArH); IR (KBr) n: 3133, 3024, 2973, 2843, 1600, 1557,
2 2 3 2
1
492, 1427, 1390, 1289, 1246, 1166, 1116, 1022, 920, 819,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet